期刊文献+

U50,488H抗大鼠缺血/再灌注损伤心律失常作用与抑制钠通道电流有关 被引量:8

Anti-arrhythmic effects of U50,488H involving the inhibition of Na^+ current in ischemia/reperfusion rat heart
下载PDF
导出
摘要 目的观察κ阿片受体选择性激动剂(U50,488H)对大鼠心脏缺血/再灌注(ischemia and reperfusion,I/R)室性心律失常的影响并探讨其可能的机制。方法观察U50,488H对大鼠I/R整体动物模型血浆肌酸磷酸激酶(CK)、乳酸脱氢酶(LDH)水平的影响;分离正常大鼠心脏,采用Langen-dorff离体心脏灌流方法,预先给予U50,488H(5mmol·L-1)和NE(100μmol·L-1),测定其对血流动力学指标和对心律失常的影响;常规酶解法分离成年大鼠心室肌细胞,采用全细胞膜片钳技术观察U50,488H对钠电流的作用。结果①U50+I/R组血浆中CK和LDH的含量较I/R组明显降低(P<0.01)。②与I/R组相比,给予U50,488H后,心率明显下降(P<0.05)。③对照组偶发早搏,I/R组心律失常发生频率明显增加,与I/R组相比较,I/R+NE组心律失常评分明显增高(P<0.01);如果提前给予U50,488H,发现不仅可以明显降低I/R组缺血和再灌注期间室速和室颤的发生率(P<0.01)及降低I/R组心律失常的评分,而且明显降低I/R+NE组心律失常的评分(P<0.01)。④U50,488H(100μmol·L-1)可以明显降低心室肌细胞的钠电流(P<0.01)。结论κ阿片受体激动剂U50,488H对I/R时的心律失常有拮抗作用,其作用可能是通过抑制心肌细胞的钠电流而实现的。 Aim To investigate the effects of U50, 488H( a selective K-opioid receptor agonist)on ventricular arrhythmias induced by myocardial isehemia and reperfusion in rats and to elucidate their mechanisms. Methods The contents of CK (creatine phosphokinase) and LDH ( lactate dehydrogenase ) were measured; The isolated heart was perfused using langendorff equipment. Heart rate (HR), arterial blood pressure ( ABP ), left ventricular pressure ( LVP ), cardiac function ( ± dp/dtmax ), rate of ventricular tachycardia (VT) and ventricular fibrillation(VF) were examined in rats in vitro. The incidence of ventricular arrhythmias and arrhythmia score were also determined; The change of sodium currents (INa) induced by U50, 488H was detected by whole-cell recording mode using patch clamp. Results ① In comparison with I/R group, the contents of CK, LDH in plasma of rats in U50,488H + I/R group were significantly lowered( P 〈 0. 01 ). ②Compared with I/R group, Heart rate decrease significantly following U50,488H administration. ③ Compared with normal control group and I/R group, the incidence of ventricular arrhythmias and arrhythmia score were enhanced in I/R + NE group. However, the incidence of ventricular arrhythmias and arrhythmia score were significantly decreased with administration of U50,488H(P 〈0. 01 ). ④ INa was significantly inhibited by U50,488H ( P 〈 0. 01 ). Conclusion κ-opioid receptor agonist, U50,488H, which antagonizes the arrhythmias during myocardial ischemia and reperfusion is probably by inhibiting INa.
出处 《中国药理学通报》 CAS CSCD 北大核心 2007年第3期331-336,共6页 Chinese Pharmacological Bulletin
基金 全军医药卫生科研基金军队"十一五"面上资助项目(No06MA203) 国家自然科学基金资助项目(No30370580)
关键词 U50 488H 去甲肾上腺素 缺血/再灌注 心律失常 钠电流 U50,488H NE ischemia and reperfusion arrhythmia INa
  • 相关文献

参考文献18

  • 1BroBrooks W W,Conrad C H,Morgan J P.Reperfusion induced arrhythmias following ischaemia in intact rat heart:role of intracellular calcium[J].Cardiovasc Res,1995,29(4):536-42.
  • 2Anderson S E,Liu H,Beyschau A,Cala P M.Effects of cold cardioplegia on pH,Na,and Ca in newborn rabbit hearts[J].Am J Physiol Heart Circ Physiol,2006,290(3):H1090-7.
  • 3Anzawa R,Bernard M,Tamareille S,et al.Intracellular sodium increase and susceptibility to ischaemia in hearts from type 2 diabetic db/db mice[J].Diabetologia,2006,49(3):598-606.
  • 4Wang G Y,Wu S,Pei J M,et al.Kappa-but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats[J].Am J Physiol Heart Circ Physiol,2001,280(1):H384-91.
  • 5Tai K K,Jin W Q,Chan T K,Wong T M.Characterization of [^3H]U69593 binding sites in the rat heart by receptor binding assays[J].J Mol Cell Cardiol,1991,23(11):1297-302.
  • 6张鹏,朱运龙,王跃民,李明哲,毕辉,裴建明.к阿片受体激动剂U50488H对大鼠心肌缺血再灌注室性心律失常的影响[J].第四军医大学学报,2004,25(18):1648-1651. 被引量:10
  • 7Coles J A,Jr,Sigg D C,Iaizzo P A.Role of kappa-opioid receptor activation in pharmacological preconditioning of swine[J].Am J Physiol Heart Circ Physiol,2003,284(6):H2091-9.
  • 8裴建明,毕辉,朱妙章.阿片样物质与心脏缺血预处理[J].生理科学进展,2003,34(1):63-66. 被引量:7
  • 9姚青,王跃民,张鹏,毕辉,裴建明.к阿片受体介导的抗心律失常作用[J].心脏杂志,2004,16(2):109-112. 被引量:13
  • 10Dominguez G,Fozzard H A.Influence of extracellular K^+ concentration on cable properties and excitability of sheep cardiac Purkinje fibers[J].Circ Res,1970,26(5):565-74.

二级参考文献25

  • 1[1]Yellon DM, Baxter GF. A "second window of protection'' or delayed preconditioning phenomenon: future horizons for myocardial protection? J Mol Cell Cardiol,1995,27:1023~1034.
  • 2[2]Schultz JJ, Hsu AK, Gross GJ. Ischemic preconditioning is mediated by a peripheral opioid receptor mechanism in the intact rat heart. J Mol Cell Cardiol, 1997, 29:1355~1362.
  • 3[3]Schultz JJ, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide sensitive mechanism in the rat heart. Circ Res, 1996, 78:1100~1104.
  • 4[4]Liang BT, Gross GJ. Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ Res, 1999, 84:1396~1400.
  • 5[5]Schultz JJ, Hsu AK, Gross GJ. Ischemic preconditioning in the intact rat heart is mediated by d1 but not μ or κ-opioid receptors. Circulation, 1998, 97:1282~1289.
  • 6[6]Wang GY, Wu S, Pei JM, et al. κ-opioid receptor mediates cardioprotection of ischemic preconditioning- role of PKC and KATP. Am J Physiol, 2001, 280:H384~H391.
  • 7[7]Baker JE, Konorev EA, Gross GJ, et al. Resistance to myocardial ischemia in five rat strains: is there a genetic component of cardioprotection? Am J Physiol, 2000, 278:H1395~ H1400.
  • 8[8]Fryer RM, Hsu AK, Nagase H, et al. Opioid induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels. J Pharmacol Exp Ther, 2000, 294:451~457.
  • 9[9]Zhou JJ, Pei JM, Wang GY, et al. Inducible heat shock protein 70 mediates delayed cardioprotection of U50,488H pretreatment in rat ventricular myocytes. Am J Physiol, 2001, 281:H40~H47.
  • 10McTavish D, Campoli-Richards D, Sorkin EM et al.Carvedilol: A review of its pharmacological and pharmacokinetic properties, and therapeutic efficacy[J]. Drugs, 1993,45(2):232-58.

共引文献24

同被引文献96

引证文献8

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部